Prognostic performance of ferritin in combination with CT-SS and NEWS, to predict ICU admission and mortality in COVID-19
The Journal of Infection in Developing Countries · 28.02.2026 · 20 (02) · 167-174
DOI: 10.3855/jidc.21452 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 28.02.2026. Verfasst von Murat Daş und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Canakkale Onsekiz Mart University, Çanakkale, Turkey. Hauptthemen laut MEDLINE: Ferritins, COVID-19, Intensive Care Units, Early Warning Score. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created significant challenges in predicting severe disease outcomes. This study evaluates the combined prognostic performance of serum ferritin, national early warning score (NEWS), and computed tomography severity score (CT-SS) in predicting intensive care unit (ICU) admission and 30-day mortality. Methodology: This retrospective study included 693 COVID-19 patients with confirmed RT-PCR results and complete medical records. Demographic, clinical, and laboratory data, including ferritin levels, NEWS, and CT-SS, were analyzed. Statistical analyses were conducted to evaluate their individual and combined predictive capabilities.
Results
Elevated ferritin levels, higher NEWS, and greater CT-SS were significantly associated with increased ICU admission and mortality risks. Receiver operating characteristic (ROC) analysis revealed excellent predictive accuracy for mortality: ferritin (area under the receiver operating characteristic curve [AUROC]: 0.916), NEWS (AUROC: 0.927), and CT-SS (AUROC: 0.881). Integrating ferritin into NEWS and CT-SS models enhanced predictive precision, with combined scoring systems yielding the highest odds ratios for adverse outcomes. Patients with a NEWS ≥ 5 and ferritin level ≥ 275.8 had a 151-fold increased risk of mortality, while those with a CT-SS ≥ 9 and ferritin level ≥ 275.8 had a 72-fold increased risk.
Conclusions
Combining ferritin with NEWS and CT-SS improves the prognostic accuracy for predicting severe outcomes in COVID-19 patients. This study emphasizes the value of integrating laboratory markers with established scoring systems to optimize clinical decision-making. The findings can guide early interventions, reduce mortality, and improve resource utilization during pandemics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Canakkale Onsekiz Mart University, Çanakkale, Turkey.
- Department of Obstetrics and Gynecology, Canakkale Onsekiz Mart University, Çanakkale, Turkey.
- Department of Internal Medicine, Canakkale Onsekiz Mart University, Çanakkale, Turkey.
Zitieren
APA
Daş, M., Beyazıt, F., Bardakcı, O., Ünal Çetin, E., Akdur, G., Akman, C., Akdur, O., & Beyazıt, Y. (2026). Prognostic performance of ferritin in combination with CT-SS and NEWS, to predict ICU admission and mortality in COVID-19. The Journal of Infection in Developing Countries, 20(02), 167-174. https://doi.org/10.3855/jidc.21452
Vancouver
Daş M, Beyazıt F, Bardakcı O, Ünal Çetin E, Akdur G, Akman C, et al. Prognostic performance of ferritin in combination with CT-SS and NEWS, to predict ICU admission and mortality in COVID-19. The Journal of Infection in Developing Countries. 2026;20(02):167-174. doi:10.3855/jidc.21452
BibTeX
@article{Da2026,
author = {Daş, Murat and Beyazıt, Fatma and Bardakcı, Okan and Ünal Çetin, Ece and Akdur, Gökhan and Akman, Canan and Akdur, Okhan and Beyazıt, Yavuz},
title = {Prognostic performance of ferritin in combination with CT-SS and NEWS, to predict ICU admission and mortality in COVID-19},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
volume = {20},
number = {02},
pages = {167--174},
doi = {10.3855/jidc.21452}
}
EUVIMED